- Sections
- C - Chimiemétallurgie
- C07H - Sucresleurs dérivésnucléosidesnucléotidesacides nucléiques
- C07H 19/12 - Radicaux triazine
Détention brevets de la classe C07H 19/12
Brevets de cette classe: 127
Historique des publications depuis 10 ans
|
8
|
15
|
6
|
12
|
6
|
9
|
7
|
10
|
3
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Celgene Corporation | 1470 |
5 |
| Gilead Sciences, Inc. | 1974 |
5 |
| ScinoPharm Taiwan, Ltd. | 130 |
5 |
| Ohara Pharmaceutical Co., Ltd. | 36 |
5 |
| Merck Sharp & Dohme LLC | 3755 |
5 |
| Cilag AG | 12 |
4 |
| Geron Corporation | 175 |
4 |
| Emory University | 1591 |
3 |
| Epigenetics Pharma LLC | 6 |
3 |
| Southern Research Institute | 210 |
3 |
| Janssen Biopharma, Inc. | 49 |
3 |
| Centre National de La Recherche Scientifique | 10158 |
2 |
| Massachusetts Institute of Technology | 9932 |
2 |
| Board of Regents, The University of Texas System | 5658 |
2 |
| The Johns Hopkins University | 5554 |
2 |
| Jiangsu Aosaikang Pharmaceutical Co., Ltd. | 37 |
2 |
| MBC Pharma, Inc. | 11 |
2 |
| Modernatx, Inc. | 1205 |
2 |
| Oregon Health & Science University | 759 |
2 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2846 |
2 |
| Autres propriétaires | 64 |